Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia

Poe-Hirr Hsyu, Diane R. Mould, Richard N. Upton, Michael Amantea

Open source

DOI
10.1007/s00280-012-1998-4
Published
2012-10-16
Container
Cancer Chemotherapy and Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-012-1998-4,
  title = {Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia},
  author = {Poe-Hirr Hsyu and Diane R. Mould and Richard N. Upton and Michael Amantea},
  year = {2012},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-012-1998-4},
  url = {https://doi.org/10.1007/s00280-012-1998-4}
}

RIS

TY  - JOUR
TI  - Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia
AU  - Poe-Hirr Hsyu
AU  - Diane R. Mould
AU  - Richard N. Upton
AU  - Michael Amantea
PY  - 2012
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-012-1998-4
UR  - https://doi.org/10.1007/s00280-012-1998-4
ER  - 

APA

Hsyu, P., Mould, D. R., Upton, R. N., & Amantea, M. (2012). Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-012-1998-4

Source records